Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-08-22
2006-08-22
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S204000
Reexamination Certificate
active
07094792
ABSTRACT:
The present invention relates to compounds with the formula (I)and also to pharmaceutical compositions comprising the compounds, as well as to the use of the compounds in medicine and for the preparation of a medicament which acts on the human 11-β-hydroxysteroid dehydrogenase type 1 enzyme.
REFERENCES:
patent: 2362087 (1944-11-01), Newbery
patent: 4254260 (1981-03-01), Takaya et al.
patent: 5403857 (1995-04-01), Edwards et al.
patent: 5594021 (1997-01-01), Chan et al.
patent: 5783597 (1998-07-01), Beers et al.
patent: 5856347 (1999-01-01), Hashiguchi et al.
patent: 5962490 (1999-10-01), Chan et al.
patent: 6030991 (2000-02-01), Chan et al.
patent: 2003/0130258 (2003-07-01), Kurz et al.
patent: 2003/0130279 (2003-07-01), Kurz et al.
patent: 2003/0166689 (2003-09-01), Kurz et al.
patent: 2003/0176476 (2003-09-01), Barf et al.
patent: 2003/0199501 (2003-10-01), Nilsson et al.
patent: 749 964 (1996-12-01), None
patent: 0 790 057 (1997-08-01), None
patent: 819 681 (1998-01-01), None
patent: 1 069 114 (2001-01-01), None
patent: 94.123 (1968-01-01), None
patent: 2 384 498 (1978-10-01), None
patent: 620 654 (1949-03-01), None
patent: 822 947 (1959-11-01), None
patent: 2001483 (1990-01-01), None
patent: 03173876 (1991-07-01), None
patent: 687841 (1994-03-01), None
patent: 6610324 (1967-01-01), None
patent: WO 96/04912 (1996-02-01), None
patent: WO 97/07789 (1997-03-01), None
patent: WO 98/16520 (1998-04-01), None
patent: WO 98/27081 (1998-06-01), None
patent: WO 98/36770 (1998-08-01), None
patent: WO 99/02502 (1999-01-01), None
patent: WO 99/65884 (1999-12-01), None
patent: WO 00/02851 (2000-01-01), None
patent: WO 01/01971 (2001-01-01), None
patent: WO 01/52833 (2001-07-01), None
patent: WO 01/54691 (2001-08-01), None
patent: WO 01/90090 (2001-11-01), None
patent: WO 01/90091 (2001-11-01), None
patent: WO 02/28353 (2002-04-01), None
patent: WO 03/011258 (2003-02-01), None
Chemcats, “5-Thiazolecarboxylic acid, 4-methyl-2-(((4-methylphenyl)sulfonyl)amino)-, ethyl ester,” Pharma Library Collection, (May 14, 2001). Chemcats Accession No. 2001:20962, Order No. NS46076, CAS Registry No. 313230-18-1.
Chemcats, “5-Thiazolecarboxylic acid, 2-(((4-chlorophenyl) sulfonyl)amino)-4-methyl-, ethyl ester,” Pharma Library Collection, (May 14, 2001). Chemcats Acccession No. 2001:19109, Order No. NS41693, CAS Registry No. 312915-26-7.
Chemcats, “5-Thiazolecarboxylic acid, 4-methyl-2-(((3-nitrophenyl)sulfonyl)amino)-, ethyl ester,” ChemDiv, Inc. Product Library, (Apr. 26, 2001). Chemcats Accession No. 2001:786400, Order No. 0947-0103, CAS Registry No. 313237-92-2.
Chemcats, “5-Thiazolecarboxylic acid, 4-methyl-2-((phenylsulfonyl)amino)-, ethyl ester,” Pharma Library Collection, (May 14, 2001). Chemcats Accession No. 2001:2446055, Order No. NS44365, CAS Registry No. 313237-91-1.
Chemcats, “5-Thiazolecarboxylic acid, 4-methyl-2-((2-naphthalenylsufonyl)amino)-, ethyl ester,” Pharma Library Collection, (May 14, 2001). Chemcats Accession No. 2001:19110, Order No. NS41694, CAS Registry No. 312915-27-8.
Chemcats, “5-Thiazolecarboxylic acid, 4-methyl-2-((4-methylphenyl)sulfonyl)amino)-, ethyl ester,” Compounds for Screening, (Jul. 1, 2001). Chemcats Accession No. 2001:1499370, Order No. AG-690/36005052, CAS Registry No. 313230-18-1.
Chemcats, “5-Thiazolecarboxylic acid, 2-(((2-chlorophenyl)sulfonyl)amino)-4-methyl-ethyl ester,” Interbioscreen Compound Library, (Feb. 11, 2002). Chemcats Accession No. 2002:175108, Order No. STOCK2S-28380, CAS Registry No. 378764-18-2.
Chemcats, “5-Thiazolecarboxamide, 4-methyl-N-phenyl-2-((phenylsulfonyl)amino)-,” Interbioscreen Compound Library, (Feb. 11, 2002). Chemcats Accession No. 2002:174900. Order No. STOCK2S-27987, CAS Registry No. 378768-75-3.
Chemcats, “5-Thiazolecarboxamide, 2-(((2,5-dimethylphenyl)sulfonyl)amino)-4-methyl-N-phenyl-,” Interbioscreen Compound Library, (Feb. 11, 2002). Chemcats Accession No. 2002:310940, Order No. STOCK2S-37273, CAS Registry No. 380584-86-1.
Chemcats, “5-Thiazolecarboxamide, 4-methyl-2-(((4-methylphenyl)sulfonyl)amino)-N-phenyl-,” Interbioscreen Compound Library, (Feb. 11, 2002). Chemcats Accession No. 2002:310143, Order No. STOCK2S-35716, CAS Registry No. 380590-91-0.
Chemcats, “5-Thiazolecarboxylic acid, 2-(((2,5-dimethylphenyl)sulfonyl)amino)-4-methyl-, ethyl ester,” Interbioscreen Compound Library, (Feb. 11, 2002). Chemcats Accession No. 2002:312516, Order No. STOCK2S-40385, CAS Registry No. 380878-60-4.
Anton-Fox et al., “Pharmacological Studies of the Two New Hypoglycaemic Compounds 4-(3-Methyl-5-oxo-2-pyrazolin-1-hl)benzoic Acid and 1-(Mesitylen-2-sulfonyl)-1H-1,2,4-triazole,” Arzneim.-Forsch./Drug Res 1994, 44(11), No. 7, pp. 821-826.
Merck & Co. Inc., USA, 1999, Monograph No. 4488, “Glybuzole,” CAS Registry No. 1492-02-0.
Hisamitsu Pharmaceutical Oc: “Preparation of 2-(substituted amino)thiazole derivatives as esterase inhibitors,” CAPLUS Accession No. 1995:818696, 1995, Document No. 123:228174.
Hisamitsu Pharmaceutical Co: “Preparation of 2-aminothiazole derivatives as esterase inhibitors,” CAPLUS Accession No. 1995:867676, 1995, Document No. 123:256699.
Susan Budavari et al., “The Merck Index, An Encyclopedia of Chemical, Drugs, and Biologicals, Twelfth Edition,” No. 9115, 1996, pp. 1529.
Friedrich Boberg et al., “Reaction of thioxo compounds with N-chloramidines. VI. Reaction of thioquinolone, dihydrothiazolethione and dihydroisothiazole thione with sodium N-chlorobenzenesulfonamides,” CAPLUS Accession No. 1996:420288, 1996, Document No. 125:195596.
CHEMCATS Accession No. 1998:584450, Maybridge, Apr. 3, 2000, 1998.
CHEMCATS Accession No. 1998:584451, Maybridge, Apr. 3, 2000, 1998.
Asahi Chemical Ind: “Therapeutics for Alzheimer's disease containing N-(5-nitro-2-thiazoly)benzenesulfonamides,” CAPLUS Accession No. 1996:111694, Document No. 124:165271, 1996.
Hisamitsu Pharmaceutical Co: “Preparation of diphenylthiazoles as pharmaceuticals,” CAPLUS Accession No. 1991:680016, Document No. 115:280016, 1991.
Zaki El-Hewehi et al., << Sulfonic acid derivatives: preparation and applicability as mothproofing agents, >> Chemical Abstracts, vol. 58, The Abstract No. 5671, J. Prakt. Chem., 1962, pp. 297-336.
AsInEx Compound Collection, “5-Thiazolecarboxylic acid, 4-methyl-2-(((4-methylphenyl)sulfonyl)amino)-, ethyl ester,” CHEMCATS Accession No. 2001:67657, 2001.
Pharma Library Collection, “5-Thiazolecarboxylic acid, 2-(((4-chlorophenyl)sulfonyl)amino)-4-methyl-, ethyl ester,” CHEMCATS Accession No. 2001:19109, 2001.
ChemDiv, Inc. Product Library, Apr. 26, 2001, “5-Thiazolecarboxylic acid, 4-methyl-2-(((4-methylphenyl)sulfony)amino-), ethyl ester,” CHEMCATS Accession No. 2001:444469, 2001.
V.V. Berezhinskaya, “hypoglycemic activity in relation to chem. Structure of potential oral antidiabetic substances—(I) 1-sulfonyl-3-alkyluread, (II) analogs of 1-sulfonyl-3-alkylureas, (III) 2-benzene-sulfonamido-5-alkyl-1,3,4-thiadiazole and-oxadiazoles,” CAOLD Accession No. CA57:3567g, 1962.
Hans Wojahn, “Bromination of sulfapyrimidine and sulfathiazole compounds. II.,” Chemical Abstracts, vol. 51, The Abstract No. 6646d, Arch. Pharm., 1955, pp. 288, 321-336.
V.A. Krasovskii et al., << Alkylation of aminothiazoles. VII. Alkylation of 2-aminothiazole and 4-methyl-2-aminothiazole by tert-butyl alcohol, CAPLUS Accession No. 1969:115051, Document No. 70:115051, 1969.
J.D. McColl et al., Effect of Some Sulfonylurea Derivatrives in Experimental Ulcer Formation in the Rat, >> Chemical Abstracts, vol. 59, The Abstract No. 3231, Arch. Intern. Pharmacodyn, 1963, pp. 181-189.
Gaile E. Gudriniece et al., <<Heterocyclic compounds based on diketones. II. 2′-Amino-5,5-dimethyl-1-cyclohexanone(2,3:4′,5′)thiazole. I., Chemical Abstracts, vol. 59, T
Barf Tjeerd
Emond Rikard
Kurz Guido
Nilsson Marianne
Vallgårda Jerk
Anderson Rebecca
Biovitrum AB
LandOfFree
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3646085